The property was finalized in August 2020 and is currently leased by Oribalt. An expansion area of apx. 2,800 m2 was handed over to the client in 2023.
Oribalt Group provide a wide range of logistic services for pharmaceutical manufacturers such as warehousing, distribution, transportation, direct delivery models, as well as cold chain logistics, direct deliveries to patients, labelling and other services. Oribalt’s pre-wholesale service portfolio is adapted to customer needs and requirements across all Baltic region.
On the 6th of March 2023, the building was certified in accordance with the BREAM In-Use requirements with an asset performance of “Very Good”.